Pharma in Focus - knowledge in power
6 - 12 Sep 2010
 
Drug Tracker: CE rejection rate problematic for pricing
The latest Drug Tracker analysis of PBAC outcomes shows that an increasing rejection rate for major cost-effectiveness submissions may have potential to affect return on investment for new drugs and indications
Roche reacts to changing pharma environment
Roche has wasted no time in reacting to a series of delays and disappointments that have affected its business over recent months and to changing pressures in the world of drug funding
About Pharma in Focus

Pharma in Focus is Australia 's only independent pharma industry news service.

We deliver up-to-date, in-depth news, analysis and opinion straight to your desktop 48 times a year, covering the whole pharma sector, both prescription and non-prescription in Australia and New Zealand.

Who is Pharma in Focus for?
  • People in all pharmacos, including:
    • Marketing
    • Sales
    • Medical
    • Regulatory affairs
    • Communications and media
    • Strategy and planning
    • C level executives
  • People in businesses that serve pharma, including:
    • Public relations agencies
    • Advertising agencies
    • Market researchers
    • Medical media
    • Financial analysts
    • Lawyers
    • CROs
  • People in organisations that relate to pharma, including:
    • Government departments
    • Non-government organisations
    • Research institutes
    • Biotech ventures
    • Industry bodies

How will I benefit from Pharma in Focus?

  • Pharma in Focus will:
    • Save you time
    • Save you effort
    • Keep you in front
    • Put you in control

How does Pharma in Focus deliver these benefits?

Pharma in Focus is your one stop shop for pharma industry intelligence.

  • We cover:
    • Government and the Bureaucracy
    • Regulatory and Legal Affairs
    • GP, Specialist & Pharmacist Activities
    • Marketing, Media & Corporate Affairs
    • Employment
    • Industry & Research (including Biotech)
  • We talk to, quote, publish and keep tabs on:
    • Heavyweight regulators
    • Industry leaders
    • Top bureaucrats
    • Marketing gurus
    • Conference speakers
    • Leading researchers
    • Government ministers
    • Recruitment experts
  • We deliver:
    • News
    • Analysis
    • Comment
    • 48 times a year
    • PLUS breaking news updates

How do I get Pharma in Focus?

We email Pharma in Focus straight to your desktop every week (48 times a year).

You can choose the News Alert only service (free subscription) or the News Alert with Full Text (paid subscription).

The News Alert only service delivers:

  • News headlines
  • Single paragraph story briefs
  • Update on industry staff movements
  • Job listings
  • Commercial services directory

The News Alert with Full Text delivers all the above plus:

  • Full length news stories
  • Breaking news updates
  • In-depth analysis of industry issues
  • Commentary from industry leaders
  • Advisory features written by recognised industry experts
  • Full archive search facility covering hundreds of Pharma in Focus articles
  • Email to a colleague for individual articles

Full Text FREE Trial – to trial our Full Text service free for two issues, click here

Who's behind Pharma in Focus ?

Pharma in  Focus is published by Lush Media and edited by Nick Lush, former  editor of Medical Observer, voted Australia's top business to  business publication in 2002.

Nick has been in journalism for over 20 years. He possesses specialised expertise in health, research, finance and political reporting and editing.

He has an extensive knowledge of the pharmaceutical industry in Australia and its relationships with government and the private sector.

TOP | BACK

 

Welcome Guest
Instant Update: Fri 10 Sept
..full report
Roche reviews global job numbers
..full report
Sigma slapped with class action
..full report
Common code considered likely
..full report
Abbott's Reductil patent upheld
..full report
PBS processes given IT overhaul
..full report
Arimidex competitors line up
..full report
Codeine combos still a problem
..full report

© 2007 Lush Media | Privacy Statement | Subscribe to Pharma in Focus